SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
February 8, 2007
FMC CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 1-2376 | 94-0479804 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
1735 Market Street, Philadelphia, PA 19103
(Address of principal executive offices) (Zip Code)
(215) 299-6000
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| q | Written communications pursuant to Rule 425 under the Securities Act |
| q | Soliciting material pursuant to Rule 14a-2 under the Exchange Act |
| q | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
| q | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
ITEM 7.01. Regulation FD Disclosure.
On February 8, 2007, William G. Walter, Chairman, President and Chief Executive Officer, addressed a group of investors at the Chemical Analysts of New York meeting in New York, NY. Slides used in his presentation at the meeting are included hereto as an exhibit. These slides may also be accessed at the company’s website (www.fmc.com) and will be available for a period of at least thirty days.
This report is not deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.
ITEM 9.01. Financial Statements and Exhibits
(d) Exhibits.
| 99.1 | FMC presentation by William G. Walter at the Chemical Analysts of New York meeting in New York, NY, on February 8, 2007. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| FMC CORPORATION | ||
| By: | /s/ W. KIM FOSTER | |
| W. Kim Foster Senior Vice President and Chief Financial Officer | ||
Date: February 8, 2007
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 99.1 | FMC presentation by William G. Walter at the Chemical Analysts of New York meeting in New York, NY, on February 8, 2007. |